FarmPharma receives a grant of SEK 300,000 FRI, JUN 12, 2020 10:31 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call "Innovative Startups step 1". The grant will support ongoing [...]
The second interferon for the product InterferOX is manufactured MON, JUN 8, 2020 09:31 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the second recombinant bovine interferon, which is the second component of FarmPharma's product [...]
Double Bond Pharmaceutical AB has transferred its holding in FarmPharma AB to the parent company FRI, MAY 8, 2020 14:23 CET Double Bond Pharmaceutical AB has today, May 8, 2020, transferred all of its 10,000,000 shares in FarmPharma AB, which comprises 74.8 percent of the total number of [...]
First interferon for the product InterferOX is manufactured MON, MAR 16, 2020 15:08 CET FarmPharma AB, which is a subsidiary of Double Bond Pharmaceutical AB, today reported that the first recombinant bovine interferon, which is the first component of FarmPharma's product InterferOX, was manufactured. "The [...]
FarmPharma signs agreement with Karolinska Institutet MON, DEC 9, 2019 08:00 CET Today FarmPharma AB, the subsidiary of Double Bond Pharmaceutical AB, signed a collaboration agreement with Karolinska Institutet (Department of Medicine, Solna) to conduct a project of producing start material for FarmPharma products. The [...]
FarmPharma starts the project at Testa Center MON, JUL 1, 2019 08:00 CET FarmPharma AB, which is subsidiary to Double Bond Pharmaceutical AB, has today started the project at Testa Center as a part of cooperation agreement with GE Healthcare in Uppsala. As previously announced, FarmPharma [...]
FarmPharma signs agreement with Testa Center FRI, MAY 24, 2019 08:00 CET FarmPharma AB, which is subsidiary to Double Bond Pharmaceutical AB, has today signed a cooperation agreement with GE Healthcare to implement a project at Testa Center in Uppsala. As previously announced, FarmPharma has [...]
FarmPharma receives funding from Vinnova THU, APR 25, 2019 08:00 CET FarmPharma AB that is subsidiary to Double Bond Pharmaceutical Int. AB, has been funded with the amount of SEK 400,000 from Vinnova within the project ”BioProcess Innovation Center” to perform a project in collaboration [...]
FarmPharma receives EU funding SME instrument Phase I WED, APR 10, 2019 08:00 CET As previously announced, FarmPharma AB that is subsidiary to Double Bond Pharmaceutical Int. AB, has submitted an application to the European Commission for an SME instrument grant within the framework of [...]
FarmPharma raised more than SEK 2 million through a targeted share issue SAT, JAN 19, 2019 08:00 CET The Board of FarmPharma has now, with the support of the authorization received at the extraordinary general meeting on November 19, 2018, implemented a directed new issue [...]